• Home
  • News
  • Coins2Day 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
TechGoogle

Google’s staff get pricey fast COVID tests while contractors wait

By
Nico Grant
Nico Grant
,
Mark Bergen
Mark Bergen
and
Bloomberg
Bloomberg
Down Arrow Button Icon
By
Nico Grant
Nico Grant
,
Mark Bergen
Mark Bergen
and
Bloomberg
Bloomberg
Down Arrow Button Icon
January 11, 2022, 6:25 PM ET

Google offers its full-time employees working from home a supply of high-end instant Covid-19 tests. Meanwhile, the contract workers still coming into offices have to wait longer for results.

The Alphabet company allows U.S. Full-time employees and their dependents to request Covid-19 tests from Cue Health, which provide results at home within a few minutes, according to a document reviewed by Bloomberg. Contract workers who must report in-person to Google’s offices receive PCR tests by BioIQ that they can prepare and mail into a lab, according to a document that the Alphabet Workers Union tweeted Tuesday. 

Convenient access to high-quality Covid-19 testing has become a marker of social inequities in the U.S. Amid a surge of virus cases due to the spread of the omicron variant, lines for tests have grown long across the country, while supplies of at-home tests have winnowed and prices for them have ballooned on the secondary market. Test access has grown so tenuous that U.S. President Joseph Biden on Monday required insurance companies to cover the cost of at-home tests, and has said the government will soon make 500 million tests available for free.

Google’s direct employees have long enjoyed perks that the company’s vendors, temporary and contract workers, who number as many or more than direct staff, go without. Contractors, for instance, are not able to request an extra computer monitor through Google’s intranet and don’t receive Alphabet stock as part of their compensation. In the U.S., that divide now extends to their health. 

“We have many at-home and in-person viral testing options available free to our employees and members of our extended workforce, including temps and vendors,” a Google spokesperson said in a statement. The company said by providing tests, it was alleviating the current pressure on public testing resources.

Google parent Alphabet directly employs over 150,000 people. The company doesn’t disclose its contract and vendor staff totals. 

Google sends employees a Cue device and 10 rapid, at-home molecular tests, which costs $949 for consumers and are generally considered more accurate than an antigen test, as they can detect small amounts of genetic material of the virus instead of hunting for specific proteins on the virus’s surface. Full-time staff who are not required to be on campus can request up to 20 additional Cue tests per month for themselves and their dependents ages 2 and older through an internal portal, according to one of the people. Such employees are allowed to work from home indefinitely. 

Those who work at select U.S. Data centers, which includes contract and temporary workers, receive access to $75 Lucira Check It single-use rapid tests, according to a document reviewed by Bloomberg. Google said they also receive access to Cue readers on-site, but not at home. All workers, including contractors, have access to in-person testing when they are at major offices in the San Francisco Bay Area, New York and Seattle, according to two people familiar with the situation, who asked not to be identified discussing internal policies.

Ashok Chandwaney, a Google software engineer who is a member of the Alphabet Workers Union’s executive committee, said that all Google workers deserve the same treatment for the work they do.

“Google’s disparate response to protecting its workers and their communities is egregious, yet unsurprising,” Chandwaney said in a statement. “Google relies on a two-tiered workforce to deny the near majority of their workers the pay, benefits and rights they deserve in order to pad the pockets of a handful of executives and investors.”

Never miss a story: Follow your favorite topics and authors to get a personalized email with the journalism that matters most to you.

About the Authors
By Nico Grant
See full bioRight Arrow Button Icon
By Mark Bergen
See full bioRight Arrow Button Icon
By Bloomberg
See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Coins2Day
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.